PAPrajakta V. Adsule

Prajakta V. Adsule

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prajakta V. Adsule has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DEVELOPMENT OF 1H-INDAZOLE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS USING COMPUTATIONAL METHODS

    by Rajesh B. Nanaware, Anuruddha R. Chabukswar, Prajakta V. Adsule, Swati C. Jagdale, Kunal G. Raut

    Objective: Due to the rising prevalence of disorders linked to inflammation, there is a greater emphasis on the discovery and development of anti-inflammatory drugs, with a focus on producing new structural compounds. Methods: In this research, molecular docking and Molecular Dynamics (MD) simulation study were carried out to evaluate the 1H-indazole analogs as potent anti-inflammatory agents. Results: The compounds containing difluorophenyl, para-toulene and 4-methoxyphenyl group shows significant binding results (9.11, 8.80 and 8.46 kcal/mol respectively) when docked with Cyclooxygenase-2 (COX-2) enzyme 3NT1. The results of the MD simulation indicated that test compound BDF was relatively stable in the COX-2 enzymes active sites. The compound BDF-3NT1 demonstrated substantial affinities for binding with all of its aimed targets following a dynamic Molecular Mechanics with Generalized Born Surface Area (MM-GBSA) analysis. Conclusion: In accordance to this study, newly developed 1H-indazole compounds have the potential for treating inflammation.


  • Open Access

    Synthesis, Molecular Modeling and Cytotoxicity Study of New 3-Phenyl Coumarin Derivatives against in vitro Cell Lines

    by Anuruddha Chabukswar, Prajakta V. Adsule, Swati Jagdale, Dishank V. Purandare, Kunal Raut, Yash Kale

    In pursuit of more effective cancer treatments, researchers embarked on a study to enhance the coumarin derivative’s therapeutic potential. These compounds, known for their anticancer properties, have faced challenges such as increased toxicity and drug resistance. The research aimed to design, synthesize and assess new 3-phenyl coumarin derivatives specifically for breast and lung cancer treatment. Utilizing 3-oxoacyl-reductase (1T8I), a series of compounds were synthesized from aromatic aldehydes and phenylacetic acid. Among the synthesized 11 compounds that were examined, compounds C01, C04, C05 and C08 had significant cytotoxic effects on both MCF-7 and MRC-5 cell lines. Particularly, compound C08, featuring ethoxy and nitrate substitution, exhibited remarkable potential against both cancer cell lines, emphasizing its promise for further exploration in cancer therapy.

  • Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules

    by P. V. Adsule Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande

    Breast cancer has been predicted to impact over 2.3 million women annually, with 685,000 deaths occurring out of this condition globally. Breast cancer initially appears in the epithelial cells of channels or lobules of breast glandular tissue whereas less commonly from the basal cells outer layer. Even though some inhibitors have demonstrated anti-breast cancer cell activity, resistance to existing inhibitors and their severe side effects have forced to develop new derivatives. Coumarin nucleoside derivatives were therefore studied in silico, and their effectiveness against cancer cells was found. The studies consisted of ADMET properties, target prediction, MD stimulation, and drug-likeliness characterises. Out of the 12 compounds studied, compounds 2 and 4 were found most potent with binding energy (-7.091 and -7.018kcal/mol respectively). The standard erlotinib (AQ4) with a binding energy of -8.614 kcal/mol.


  • Open Access

    Synthesis and Evaluation of Analgesic and Antioxidant Activity of 3-Phenyl Coumarin Derivatives

    by Prajakta Adsule, Dishank Purandare, S. Kulkarni, R. Joshi, A. Chabukswar

    A series of 3- phenyl substituted coumarin derivatives prepared by reacting substituted aromatic aldehyde with phenylacetic acid. The chemical composition of substituted coumarin derivatives was confirmed by FT-IR, 1H NMR spectra and elemental analysis. Designed 3-phenyl coumarin derivatives were docked with Cyclooxygenase-2 (COX-2) enzyme (PDB CODE: 3Q7D). Compounds were synthesized and evaluated for in-vivo analgesic and in-vitro antioxidant activities depending upon the highest binding affinity. Compounds 02, 10, and 11 exhibited significant analgesic activity. Compounds 09, 04, 01, and 03 showed significant antioxidant potential in the DPPH method, and Compounds 05 and 07 have shown excellent scavenging potential in the nitric oxide scavenging method compared to ascorbic acid. This research work includes the synthesis of 3-phenyl coumarin scaffolds and the evaluation of their analgesic & antioxidant activity.


  • Coumarin: A Novel Tool for Multidisciplinary Activities

    by Sonali M. Jadhav, Prajakta V. Adsule, Anuruddha R. Chabukswar, Sushil S. Kore, Krishna S. Shevate

    Coumarin 2H-1-benzopyran-2-one core has been a field of attention due to its exclusive propensity to accept variable classes of replacements which proves it as the origin for multi-disciplinary activities. Many researchers replicates that coumarin derivatives synthesized by structural modifications & alterations that exhibits diverse pharmacological activities like Anticancer, Carbonic Anhydrase Inhibition, Anti-bacterial, Antifungal, Antiviral, Anticoagulant, Anti Alzheimer activity, Anticonvulsant Activity, Anti-inflammatory etc.The motive of this study is to review, various substituted coumarin derivatives and provide the opportunity of designing & synthesizing novel coumarin based drugs and exploring their possible derivatives in the cure of numerous disorders. This review summerizes the recent development in synthesis of Coumarin based derivatives with various biological activities.

  • Design, Synthesis, Anti-inflammatory & Anticonvulsant Activity of Substituted Heterocyclic Compounds

    by Prajakta V. Adsule, Anuruddha R. Chabukswar, Rajesh Nanaware

    Aim: To design, synthesize, anti-inflammatory & anticonvulsant activity of substituted coumarin acetohydrazide derivatives. Study Design: Experimental work related to Anti-inflammatory & Anticonvulsant activity. Methodology: Coumarin acetohydrazide derivatives were synthesized by reacting substituted isatin with 7-hydroxy-4-methyl-coumarin in glacial acetic acid to determine their anti-inflammatory & anticonvulsant activities. Molecular docking study was performed against the COX enzyme for anti-inflammatory activity & carbonic anhydrase II enzyme for anticonvulsant activity. Anti-inflammatory activity was done by carrageenan induced paw edema method in rats at a dose of 200 mg/kg body weight. Anticonvulsant activity was studied in rats at a dose of 200 mg/kg body weight; in the maximal electroshock (MES) induced seizures model. Results: (Z)-2-(4,8-dimethyl-2-oxo-2H-chromen-7-yl)oxy)-N-(5-nitro-2-oxoindolin-3-ylidine) aceto-hydrazide and (Z)-2-(4-methyl-2-oxo-2H-chromen-7yl) oxy)-N-(1-methyl-2-oxoindolin-3-ylidene) acetohydrazide showed the highest anti-inflammatory activity as compared to Celecoxib after 5 h with 71.94 to 77.96 % inhibition. Most of the compounds displayed anticonvulsant activity in the MES screen at a dose 200 mg/kg. Out of twelve compounds (Z)-N-(5-chloro-2-oxoindolin-3-ylidene)-2-((4-methyl-2-oxo-2H-chromen-7-yl) oxy) acetohydrazide and (Z)-2-((4-methyl-2-oxo-2H-chromen-7yl) oxy)-N-(1-methyl-2-oxoindolin-3-ylidene) acetohydrazide shown most significant activity with remarkable protection (67%) against MES induced convulsions. The structure-activity relationship concluded valuable pharmacophoric information, that the substitution on isatin ring has a significant effect on preventing inflammation & the seizure formation. Conclusion: From the molecular docking study & biological activity determines that all synthesized coumarin acetohydrazide derivatives shows anti-inflammatory activity as compared to Celecoxib & anticonvulsant activity as compared to Phenytoin.


  • Design, Synthesis and Antibacterial, Antifungal Activity of Some Coumarin Acetohydrazide Derivatives

    by A. R. Chabukswar, P.V. Adsule, P.B. Randhave, Manini Mantri

    We have designed and synthesized (Z)-2-(5-methyl-2-oxo-2H-chromen-7-yl) oxy)-N’-(2-oxoindolin-3-ylidin) acetohydrazide derivatives by reacting 7-hydroxy-4-methyl-coumarin and substituted isatin to afford 12 substituted coumarin acetohydrazide derivatives. The synthesized compounds of coumarin acetohydrazide derivatives were designed and evaluated to study for their possible interactions as DNA gyrase inhibitors. All the synthesized coumarin acetohydrazide compounds have been characterized by spectral analysis IR, 1H NMR and mass spectroscopy. The compounds have been evaluated for In vitro antibacterial and antifungal activity against S. aureus, B. subtilus, E. coli, P. aeruginosa and fungi C. albicans and A. niger. In case of Gram positive bacteria and Gram negative bacteria Compound P5C, M5C, C5C exhibited significant activity. Compounds P5N, M5N, C5N shown moderate activity. Compound P5C, M5C, C5C shown significant Antifungal activity against C. albicans and A. niger. Compounds P5C, M5C, C5C are found to exert significant antibacterial as well as antifungal activity and can serve as potential compound against infectious diseases in future.